secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001801170-26-000069
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health publishes supplemental Q&A re Q4 2025 earnings
------------------------------------------------------------

- Filed under Item 7.01; responses to frequently asked questions from shareholders.
- Document is furnished as Exhibit 99.1; available on investor relations page.
- No new financial results or guidance disclosed in the 8-K filing body.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000069/0001801170-26-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000069/clov-20260306.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer